Author:
Scheuermann R. H.,Racila E.,Uhr J. W.
Publisher
Springer Berlin Heidelberg
Reference14 articles.
1. Krolick, K.A., Uhr, J.W., Slavin, S. & Vitetta, E.S. In vivo therapy of a murine B cell tumor (BCL1) using antibodv-ricin A chain immunotoxins. (1982) J. Exp. Med. 155, 1797–1809.
2. George, J.J.T., Tutt, A.L. & Stevenson, F.K., Anti-idiotvpic mechanisms involved in suppression of a mouse B cell lymphoma BCL1.. (1987) J Immunol. 138, 628–634.
3. Yefenof, E., Picker, L.J., Scheuermann, R.H., Tucker, T.F., Vitetta, E.S. & Uhr, J.W. Cancer dormancy: isolation and characterization of dormant lymphoma cells. (1993) ProcNatlAcad.Sci.USA. 90, 1829–1833.
4. Scheuermann, R.H., Racila, E. Tucker, T., Yefenof, E., Street, N.E., Vitetta, E.S., Picker, L.J. & Uhr, J.W. Lyn tyrosine kinase signals cell cycle arrest but not apoptosis in B-lineage lymphoma cells (1994) Proc Natl Acad.Sci. U.SA. 91, 4048–4052.
5. Cambier, J.C. & Campbell, K.S. Membrane immunoglobulin and its accomplices: new lessons from an old receptor. (1992) FASEB J. 6, 3207–3217.